Cargando…
Differential Expression of Insulin-Like Growth Factor-I Receptor on Human Bone Marrow-Derived Mesenchymal Stem Cells Induced by Tumor Necrosis Factor-α
Background: Cell-based therapy has been implicated in the treatment of liver diseases. Mesenchymal stem cells from various sources such as bone marrow are available. These cells are one of the major candidates in cell therapy. The production of insulin-like growth factor-I increases in the regenerat...
Autores principales: | Sahraean, Z., Ayatollahi, M., Yaghobi, R., Ziaei, R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Avicenna Organ Transplantation Institute
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4089332/ https://www.ncbi.nlm.nih.gov/pubmed/25013674 |
Ejemplares similares
-
Human Bone Marrow-derived Mesenchymal Stem Cell: A Source for Cell-Based Therapy
por: Ayatollahi, M., et al.
Publicado: (2012) -
Decorin inhibits the insulin-like growth factor I signaling in bone marrow mesenchymal stem cells of aged humans
por: Wong, Tze-Hong, et al.
Publicado: (2020) -
Overexpression of Insulin-Like Growth Factor 1 Enhanced the Osteogenic Capability of Aging Bone Marrow Mesenchymal Stem Cells
por: Chen, Ching-Yun, et al.
Publicado: (2017) -
Regulation of Tumor Necrosis Factor-α by Peptide Lv in Bone Marrow Macrophages and Synovium
por: Mukai, Manabu, et al.
Publicado: (2021) -
483 Immunomodulatory Effects of Human Bone Marrow-derived Mesenchymal Stem Cells
por: Ayatollahi, Maryam, et al.
Publicado: (2012)